http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0423240-A4

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2006
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
filingDate 1989-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1992-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0423240-A4
titleOfInvention Method of modulating virus-host cell interactions using carbohydrates and carbohydrate derivatives
abstract The invention discloses novel methods of inhibiting infection of cells by a virus. Carbohydrate blocking agents capable of interacting with the cells or virus are provided which are contacted with the cells under conditions selected to effect interaction of the carbohydrate blocking agent with the cells or virus resulting in interference with binding of the virus with the cells. Suitable carbohydrate blocking agents include but are not limited to linear and cyclodextrins as well as chemically modified derivatives thereof. The invention also provides methods of inhibiting formation of syncytia between cells or virus utilizing linear and cyclodextrins and chemically modified derivatives thereof. The invention further provides methods of inhibiting viral transcriptase utilizing chemically modified derivatives of cyclodextrins. The invention also discloses compositions comprising alpha-, beta-, or gamma-cyclodextrin in combination with nucleoside derivatives or a steroid or non-steroid growth modulating agent which may be used to inhibit virus infection and syncytia formation.
priorityDate 1988-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12310447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226457444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14558278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135463029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3663
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21151265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44630569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395426
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398597

Total number of triples: 72.